Erhardt, Andreas

Publishing since 1997 (Senior)

Has published 55 publications in 14 years

Number of publications published per year by Erhardt, Andreas. (Source : PubMed)

Distribution of publications types for Erhardt, Andreas. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Kröpil P, Erhardt A, Mehnert S, Beck A, Häussinger D, Mödder U, Blondin D. Image quality and bile duct volumetry in MR cholangiopancreatography augmented with low-dose morphine.  AJR Am J Roentgenol  2010;194;2  
•  van Bömmel F, de Man RA, Wedemeyer H, Deterding K, Petersen J, Buggisch P, Erhardt A, Hüppe D, Stein K, Trojan J, Sarrazin C, Böcher WO, Spengler U, Wasmuth HE, Reinders JG, Möller B, Rhode P, Feucht HH, Wiedenmann B, Berg T. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.  Hepatology  2010;51;1  
•  Zachou K, Yurdaydin C, Drebber U, Dalekos GN, Erhardt A, Cakaloglu Y, Degertekin H, Gurel S, Zeuzem S, Bozkaya H, Schlaphoff V, Dienes HP, Bock TC, Manns MP, Wedemeyer H. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.  Liver Int.  2009  
•  Erhardt A, Göbel T, Ludwig A, Lau GK, Marcellin P, van Bömmel F, Heinzel-Pleines U, Adams O, Häussinger D. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.  J. Med. Virol.  2009;81;10  
•  Kroeger I, Erhardt A, Abt D, Fischer M, Biburger M, Rau T, Neuhuber WL, Tiegs G. The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice.  J. Hepatol.  2009;51;2  
•  Brenndörfer ED, Karthe J, Frelin L, Cebula P, Erhardt A, Schulte am Esch J, Hengel H, Bartenschlager R, Sällberg M, Häussinger D, Bode JG. Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase.  Hepatology  2009;49;6  
•  Erhardt A, Deterding K, Benhamou Y, Reiser M, Forns X, Pol S, Calleja JL, Ross S, Spangenberg HC, Garcia-Samaniego J, Fuchs M, Enríquez J, Wiegand J, Stern J, Wu K, Kukolj G, Marquis M, Beaulieu P, Nehmiz G, Steffgen J. Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment.  Antivir. Ther. (Lond.)  2009;14;1  
•  Chechko N, Wehrle R, Erhardt A, Holsboer F, Czisch M, Sämann PG. Unstable prefrontal response to emotional conflict and activation of lower limbic structures and brainstem in remitted panic disorder.  PLoS ONE  2009;4;5  
•  Cornberg M, Protzer U, Dollinger MM, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns MP. The German guideline for the management of hepatitis B virus infection: short version.  J. Viral Hepat.  2008;15 Suppl 1  
•  Mallach S, Ramp U, Erhardt A, Schmitt M, Häussinger D. An uncommon cause of gastro-duodenal ulceration.  World J. Gastroenterol.  2008;14;16  

[ See timeline ] [ See all publications ]